Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy Article

Acosta, Maria F, Muralidharan, Priya, Grijalva, Carissa L et al. (2021). Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy . 15 10.1177/1753466621998245

Open Access

cited authors

  • Acosta, Maria F; Muralidharan, Priya; Grijalva, Carissa L; Abrahamson, Michael D; Hayes, Don; Fineman, Jeffrey R; Black, Stephen M; Mansour, Heidi M

sustainable development goals

authors

publication date

  • March 1, 2021

webpage

keywords

  • Life Sciences & Biomedicine
  • Respiratory System
  • Science & Technology
  • advanced spray drying
  • dry powder inhalers
  • in vitro human cells
  • in vivo lamb
  • in vivo rat
  • inhalation aerosol medicine
  • targeted pulmonary drug delivery

Digital Object Identifier (DOI)

publisher

  • SAGE PUBLICATIONS LTD

volume

  • 15